e-Drug3D

2061

M DEUCRAVACITINIB

INN
DEUCRAVACITINIB

cas 1609393-48-7

CLASS

IMMUNOSUPPRESSANTS
IMMUNOMODULATING AGENTS
TYROSINE KINASE 2 (TYK2) ALLOSTERIC INHIBITOR
TREATMENT OF ADULTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS
BMT-153261 ACCOUNTS FOR APPROXIMATELY 20 PERCENT OF THE SYSTEMIC EXPOSURE

ROUTE (list)

ATC code

L04AF07

PK parameters

Target

TARGET TYROSINE KINASE 2 (TYK2)

DrugCentral

tyrosine kinase 2 (TYK2) UNIPROT P29597

Download SDF file

3-Pyridazinecarboxamide, 6-[(cyclopropylcarbonyl)amino]-4-[[2-methoxy-3-(1H-1,2,4-triazol-5-yl)phenyl]amino]-N-(methyl-d3)- (ACI)

Formula:
C19H17D3N8O3

Calculated chemical properties:

MW 408.43
NB_atoms 30
XLogP 1.72
PSA 131.141
NB_HD 4
NB_HA 11
fsp3 0.26
Lipinski(0=no;1=yes) 0

FDA
-